| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.69B | 21.96B | 7.87B | 8.02B | 8.13B | 23.32B |
| Gross Profit | 7.69B | 7.95B | 7.87B | 8.02B | 8.13B | 7.83B |
| EBITDA | 0.00 | 4.96B | 9.18B | 0.00 | 4.81B | 4.80B |
| Net Income | 3.79B | 3.92B | 3.78B | 3.65B | 3.83B | 3.71B |
Balance Sheet | ||||||
| Total Assets | 603.75B | 610.70B | 589.99B | 576.79B | 533.78B | 503.88B |
| Cash, Cash Equivalents and Short-Term Investments | 32.39B | 31.58B | 8.16B | 35.72B | 28.45B | 39.19B |
| Total Debt | 85.66B | 169.76B | 9.00B | 94.55B | 85.10B | 72.86B |
| Total Liabilities | 550.70B | 560.68B | 537.68B | 528.37B | 489.81B | 464.89B |
| Stockholders Equity | 53.04B | 50.01B | 52.31B | 48.42B | 43.97B | 38.99B |
Cash Flow | ||||||
| Free Cash Flow | -22.90B | 2.84B | -5.17B | -5.45B | -4.51B | -1.17B |
| Operating Cash Flow | -22.72B | 2.94B | -4.96B | -5.16B | -4.27B | -649.39M |
| Investing Cash Flow | -24.44B | -14.44B | -17.56B | 4.78B | -1.04B | 6.83B |
| Financing Cash Flow | 16.30B | 16.08B | 7.41B | 36.92B | 11.75B | 13.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$16.15B | 7.00 | 7.72% | 3.57% | 6.65% | 16.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | HK$14.44B | 3.84 | 5.60% | 5.32% | -1.24% | 4.34% | |
60 Neutral | HK$14.33B | 1.84 | 4.62% | 6.13% | -3.34% | -22.01% | |
58 Neutral | HK$12.06B | 1.69 | 3.11% | 4.24% | -7.58% | 12.65% | |
57 Neutral | HK$15.10B | 2.83 | 4.11% | ― | -5.76% | 18.15% | |
54 Neutral | HK$16.01B | -6.21 | 3.63% | 1.89% | -5.02% | -3.28% |